GlassScriptPhysician profile
Mark Raymond Hanley
NPI 1063487676
$1,404.44
in general payments reported to CMS, 2019-2025
27 companies · $14.07 in 2025
The $14.07 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $67.65 · 2021: $490 · 2022: $308 · 2023: $257 · 2024: $88.53 · 2025: $14.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stability Biologics, LLC | $284.06 | 2021 | |
| Heron Therapeutics, INC. | $238.12 | 2022-2023 | Zynrelef |
| Daiichi Sankyo INC. | $124.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $78.02 | 2019-2022 | |
| Tela Bio, INC. | $71.99 | 2020-2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $68.77 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $49.83 | 2019-2021 | |
| Allergan, INC. | $45.07 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $31.79 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.15 | 2021-2022 | |
| Smith+Nephew, INC. | $30.13 | 2020-2025 | Pico 14 |
| Pfizer INC. | $28.31 | 2019 | |
| Organogenesis INC. | $25.11 | 2023 | Puraply |
| Baxter Healthcare | $25.09 | 2019 | |
| Hologic Sales and Service, LLC | $24.95 | 2023 | Coolseal Generator |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $24.32 | 2023 | Irrisept |
| Csl Behring | $24.31 | 2019 | |
| Innocoll Pharmaceuticals Limited | $23.92 | 2021 | |
| Tactile Systems Technology INC | $22.77 | 2019-2021 | |
| Baudax Bio INC. | $22.66 | 2022 | |
| Kci USA, INC. | $22.56 | 2023 | Prevena |
| Integra Lifesciences Corporation | $21.60 | 2019 | |
| Kerecis Limited | $19.76 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Shire North American Group INC | $18.19 | 2019 | |
| Coloplast Corp | $16.27 | 2020 | |
| Abbvie INC. | $16.25 | 2023 | |
| Convatec INC. | $15.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.